Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.77 and traded as high as $1.00. Mesoblast shares last traded at $0.98, with a volume of 1,290 shares traded.
Mesoblast Price Performance
The firm’s 50-day simple moving average is $0.86 and its 200 day simple moving average is $0.78.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- Stock Market Upgrades: What Are They?
- Top-Performing Non-Leveraged ETFs This Year
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
